Xencor
+$1.99 (+5.16%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Xencor and other stocks, options, and ETFs commission-free!
About XNCR
Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions.
CEO
Bassil I. Dahiyat
Employees
202
Headquarters
Monrovia, California
Founded
1997
XNCR Key Statistics
Market Cap
2.36B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
213.82K
High Today
$40.65
Low Today
$38.25
Open Price
$38.56
Volume
260.16K
52 Week High
$58.35
52 Week Low
$27.38
Analyst Ratings
92%
of 12 ratings
Buy
91.7%
Hold
0%
Sell
8.3%
XNCR Earnings
-$0.69
-$0.47
-$0.26
-$0.04
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.69 per share
Actual
-$0.04 per share